498
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Field seasonal influenza vaccine effectiveness

Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season

, , , , , , , , & show all
Pages 2453-2459 | Received 12 Mar 2013, Accepted 24 Jun 2013, Published online: 28 Jun 2013

References

  • Guthmann JP, Fonteneau L, Bonmarin I, Lévy-Bruhl D. Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. Vaccine 2012; 30:995 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.12.011; PMID: 22178520
  • Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H. [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med 2012; 41:e568 - 76; http://dx.doi.org/10.1016/j.lpm.2012.05.017; PMID: 22795870
  • Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. Vaccine 2011; 29:4632 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.04.064; PMID: 21550376
  • Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec 2010; 85:81 - 92; PMID: 20210260
  • Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D. First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 2012; 17:17; PMID: 22587956
  • Kissling E, Valenciano M, I-MOVE Case-Control Studies Team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012; 17:17; PMID: 22516046
  • Valleron AJ, Bouvet E, Garnerin P, Ménarès J, Heard I, Letrait S, et al. A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 1986; 76:1289 - 92; http://dx.doi.org/10.2105/AJPH.76.11.1289; PMID: 3766824
  • Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10:212 - 41; PMID: 3066628
  • Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985; 63:1055 - 68; PMID: 3879673
  • Legrand J, Vergu E, Flahault A. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 2006; 24:6605 - 11; http://dx.doi.org/10.1016/j.vaccine.2006.05.063; PMID: 16806607
  • Costagliola D. When is the epidemic warning cut-off point exceeded?. Eur J Epidemiol 1994; 10:475 - 6; http://dx.doi.org/10.1007/BF01719680; PMID: 7843360
  • Review of the 2010–2011 winter influenza season, northern hemisphere. Wkly Epidemiol Rec 2011; 86:222 - 7; PMID: 21661271
  • Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623 - 31; http://dx.doi.org/10.1093/ije/dym021; PMID: 17403908
  • Cardellino A, Khawaja S, Sanchez Cruz E, Mast TC. Effectiveness of vaccination with the pentavalent rotavirus vaccine in Nicaragua as determined using the screening method. Hum Vaccin Immunother 2013; 9; In Press. http://dx.doi.org/10.4161/hv.24338; PMID: 23570049
  • Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381 - 8; http://dx.doi.org/10.1016/j.vaccine.2010.09.010; PMID: 20851086
  • Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, et al, cycEVA Study Team, Spanish Influenza Sentinel Surveillance System. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Vaccine 2012; 30:3595 - 602; http://dx.doi.org/10.1016/j.vaccine.2012.03.048; PMID: 22472792
  • Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One 2011; 6:e27622; http://dx.doi.org/10.1371/journal.pone.0027622; PMID: 22110695
  • Englund H, Campe H, Hautmann W. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2012; 1 - 9; In Press. http://dx.doi.org/10.1017/S0950268812002282; PMID: 23098364
  • Pebody RG, Andrews N, Fleming DM, McMenamin J, Cottrell S, Smyth B, et al. Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom. Epidemiol Infect 2012; 1 - 11; In Press. PMID: 22691710
  • Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, Guevara M, et al, Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study. Vaccine 2012; 30:195 - 200; http://dx.doi.org/10.1016/j.vaccine.2011.11.024; PMID: 22100636
  • Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ 2012; 344:d7901; http://dx.doi.org/10.1136/bmj.d7901; PMID: 22277542
  • Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, et al. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 2011; 6:e19621; http://dx.doi.org/10.1371/journal.pone.0019621; PMID: 21573005
  • Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309 - 15; http://dx.doi.org/10.1093/infdis/jir015; PMID: 21378375
  • Hannoun C, Dab W, Cohen JM. A new influenza surveillance system in France: the Ile-de-France “GROG”. 1. Principles and methodology. Eur J Epidemiol 1989; 5:285 - 93; http://dx.doi.org/10.1007/BF00144828; PMID: 2792306
  • Falchi A, Amoros JP, Arena C, Arrighi J, Casabianca F, Andreoletti L, et al. Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006-2010. PLoS One 2011; 6:e24471; http://dx.doi.org/10.1371/journal.pone.0024471; PMID: 21935413
  • Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22:742 - 6; http://dx.doi.org/10.1093/ije/22.4.742; PMID: 8225751
  • Cohen AL, Taylor T Jr., Farley MM, Schaffner W, Lesher LJ, Gershman KA, et al. An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One 2012; 7:e41785; http://dx.doi.org/10.1371/journal.pone.0041785; PMID: 22870248
  • Privileggio L, Falchi A, Grisoni ML, Souty C, Turbelin C, Fonteneau L, et al. Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners. BMC Public Health 2013; 13:246; http://dx.doi.org/10.1186/1471-2458-13-246; PMID: 23514534

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.